Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Donor Immunization with WT1 Peptide Augments Anti-Leukemic Activity After MHC-Matched Bone Marrow Transplantation

Holbrook E Kohrt, MD, Antonia MS Mueller, MD, Jeanette B Baker, PhD, Matthew J Goldstein, PhD, Evan Newell, PhD, Suparna Dutt, PhD, Debra K Czerwinski, Robert Lowsky, MD, Samuel Strober, MD

Blood (2011) 118 (21): 1896.

https://doi.org/10.1182/blood.V118.21.1896.1896

Published: 2011

Journal Articles

Donor immunization with WT1 peptide augments antileukemic activity after MHC-matched bone marrow transplantation

Holbrook E. Kohrt, Antonia Müller, Jeanette Baker, Matthew J. Goldstein, Evan Newell, Suparna Dutt, Debra Czerwinski, Robert Lowsky, Samuel Strober

Blood (2011) 118 (19): 5319–5329.

https://doi.org/10.1182/blood-2011-05-356238

Published: 2011

Includes: Supplemental data

Journal Articles

Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment

Ash A. Alizadeh, Andrew J. Gentles, Alvaro J. Alencar, Chih Long Liu, Holbrook E. Kohrt, Roch Houot, Matthew J. Goldstein, Shuchun Zhao, Yasodha Natkunam, Ranjana H. Advani, Randy D. Gascoyne, Javier Briones, Robert J. Tibshirani, June H. Myklebust, Sylvia K. Plevritis, Izidore S. Lossos, Ronald Levy

Blood (2011) 118 (5): 1350–1358.

https://doi.org/10.1182/blood-2011-03-345272

Published: 2011

Includes: Supplemental data

Journal Articles

CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies

Holbrook E. Kohrt, Roch Houot, Matthew J. Goldstein, Kipp Weiskopf, Ash A. Alizadeh, Josh Brody, Antonia Müller, Russell Pachynski, Debra Czerwinski, Steven Coutre, Mark P. Chao, Lieping Chen, Thomas F. Tedder, Ronald Levy

Blood (2011) 117 (8): 2423–2432.

https://doi.org/10.1182/blood-2010-08-301945

Published: 2011

Includes: Supplemental data

Journal Articles

A CpG-loaded tumor cell vaccine induces antitumor CD4 + T cells that are effective in adoptive therapy for large and established tumors

Matthew J. Goldstein, Bindu Varghese, Joshua D. Brody, Ranjani Rajapaksa, Holbrook Kohrt, Debra K. Czerwinski, Shoshana Levy, Ronald Levy

Blood (2011) 117 (1): 118–127.

https://doi.org/10.1182/blood-2010-06-288456

Published: 2011

Includes: Supplemental data

Journal Articles

Prediction of Survival In Diffuse Large B-Cell Lymphoma Based On the Expression of Two Genes Reflecting Tumor and Microenvironment

Ash A. Alizadeh, MD/PhD, Andrew J. Gentles, Ph.D., Alvaro J. Alencar, MD, Holbrook E Kohrt, MD, Roch Houot, MD/PhD, Matthew J Goldstein, BA, Shuchun Zhao, Ph.D., Yasodha Natkunam, MD, PhD, Ranjana Advani, MD, Randy D. Gascoyne, MD, Javier Briones, MD, Robert J. Tibshirani, Ph.D., June Helen Myklebust, PhD, Sylvia K. Plevritis, PhD, Izidore S Lossos, MD, Ronald Levy, MD

Blood (2010) 116 (21): 2006.

https://doi.org/10.1182/blood.V116.21.2006.2006

Published: 2010

Journal Articles

CD137 Identifies a Population of Regulatory T Cells That Inhibit Anti-Tumor Immune Responses In Adoptive Immunotherapy

Matthew J Goldstein, BA, Holbrook E Kohrt, MD, Roch Houot, MD/PhD, Bindu Varghese, PhD, Jack T Lin, PhD, Erica Swanson, BA, Ronald Levy, MD

Blood (2010) 116 (21): 2093.

https://doi.org/10.1182/blood.V116.21.2093.2093

Published: 2010

Journal Articles

Noninvasive Prediction of Graft-Verus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation by Gene Expression Profiling

Holbrook E Kohrt, MD, Li Li, PhD, Ash A Alizadeh, MD/PhD, Matthew J Goldstein, MD, Samuel Strober, MD, Minnie Sarwal, MD/PhD, Robert Lowsky, MD

Blood (2010) 116 (21): 896.

https://doi.org/10.1182/blood.V116.21.896.896

Published: 2010

Journal Articles

Immunomodulation of NK Cells through 4-1BB (CD137) to Improve the Anti-Lymphoma Activity of Rituximab: Antibody-Based Anti-Lymphoma Synergy

Holbrook E Kohrt, MD, Roch Houot, MD/PhD, Matthew J Goldstein, MD, Kipp Weiskopf, MD, Mark Chao, MD, Lieping Chen, MD/PhD, Thomas Tedder, PhD, Ron Levy, MD

Blood (2010) 116 (21): 422.

https://doi.org/10.1182/blood.V116.21.422.422

Published: 2010

Journal Articles

Adoptive Therapy for Lymphoma with CD4 Memory T Cells Depleted of CD137-Expressing Tregs.

Matthew J Goldstein, Roch Houot, MD, Holbrook E Kohrt, MD, Joshua Brody, MD, Ronald Levy, MD

Blood (2009) 114 (22): 1693.

https://doi.org/10.1182/blood.V114.22.1693.1693

Published: 2009

Journal Articles

Therapeutic Potential of Anti-CD137 Antibody in Lymphoma.

Roch Houot, MD, Matthew J Goldstein, Holbrook E Kohrt, MD, June H Myklebust, PhD, Ash A Alizadeh, MD, PhD, Jack T Lin, PhD, Jonathan M Irish, PhD, James A Torchia, Arne Kolstad, MD, PhD, Lieping Chen, MD, PhD, Ronald Levy, MD

Blood (2009) 114 (22): 722.

https://doi.org/10.1182/blood.V114.22.722.722

Published: 2009

Journal Articles

Adoptive Cell Therapy for Lymphoma: Use of CpG-Loaded Tumor Cells to Generate Potent Anti-Tumor CD4 T Cell Immunity.

Matthew J Goldstein, Bindu Varghese, PhD, Ranjani Rajapaksa, PhD, Joshua Brody, MD, Shoshana Levy, PhD, Ronald Levy, MD

Blood (2009) 114 (22): 929.

https://doi.org/10.1182/blood.V114.22.929.929

Published: 2009

Journal Articles

Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by T reg depletion

Roch Houot, Matthew J. Goldstein, Holbrook E. Kohrt, June H. Myklebust, Ash A. Alizadeh, Jack T. Lin, Jonathan M. Irish, James A. Torchia, Arne Kolstad, Lieping Chen, Ronald Levy

Blood (2009) 114 (16): 3431–3438.

https://doi.org/10.1182/blood-2009-05-223958

Published: 2009

Includes: Supplemental data

Journal Articles

Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors

Joshua D. Brody, Matthew J. Goldstein, Debra K. Czerwinski, Ronald Levy

Blood (2009) 113 (1): 85–94.

https://doi.org/10.1182/blood-2008-05-155457

Published: 2009

Includes: Supplemental data

Journal Articles

A CpG-Activated Whole-Cell Vaccine ‘Boost’ Enhances the Anti- Lymphoma Efficacy of Immunotransplant

Joshua Brody, MD, Matthew J. Goldstein, Ronald Levy, MD

Blood (2008) 112 (11): 3627.

https://doi.org/10.1182/blood.V112.11.3627.3627

Published: 2008

Journal Articles

TLR-9 Activated Lymphoma B Cells Induce Anti-Tumor Immunity in a Murine Model

Matthew J. Goldstein, Joshua Brody, MD, Ronald Levy, MD

Blood (2008) 112 (11): 4992.

https://doi.org/10.1182/blood.V112.11.4992.4992

Published: 2008

Journal Articles

Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC -induced lymphomagenesis

Catherine M. Shachaf, Omar D. Perez, Sawsan Youssef, Alice C. Fan, Sailaja Elchuri, Matthew J. Goldstein, Amy E. Shirer, Orr Sharpe, Joy Chen, Dennis J. Mitchell, Maria Chang, Garry P. Nolan, Lawrence Steinman, Dean W. Felsher

Blood (2007) 110 (7): 2674–2684.

https://doi.org/10.1182/blood-2006-09-048033

Published: 2007

Includes: Supplemental data

NARROW

Donor Immunization with WT1 Peptide Augments Anti-Leukemic Activity After MHC-Matched Bone Marrow Transplantation

Donor immunization with WT1 peptide augments antileukemic activity after MHC-matched bone marrow transplantation

Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment

CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies

A CpG-loaded tumor cell vaccine induces antitumor CD4 + T cells that are effective in adoptive therapy for large and established tumors

Prediction of Survival In Diffuse Large B-Cell Lymphoma Based On the Expression of Two Genes Reflecting Tumor and Microenvironment

CD137 Identifies a Population of Regulatory T Cells That Inhibit Anti-Tumor Immune Responses In Adoptive Immunotherapy

Noninvasive Prediction of Graft-Verus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation by Gene Expression Profiling

Immunomodulation of NK Cells through 4-1BB (CD137) to Improve the Anti-Lymphoma Activity of Rituximab: Antibody-Based Anti-Lymphoma Synergy

Adoptive Therapy for Lymphoma with CD4 Memory T Cells Depleted of CD137-Expressing Tregs.

Therapeutic Potential of Anti-CD137 Antibody in Lymphoma.

Adoptive Cell Therapy for Lymphoma: Use of CpG-Loaded Tumor Cells to Generate Potent Anti-Tumor CD4 T Cell Immunity.

Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by T reg depletion

Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors

A CpG-Activated Whole-Cell Vaccine ‘Boost’ Enhances the Anti- Lymphoma Efficacy of Immunotransplant

TLR-9 Activated Lymphoma B Cells Induce Anti-Tumor Immunity in a Murine Model

Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC -induced lymphomagenesis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only